These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 29197671)
1. The in vitro renal cell toxicity of some unconventional anticancer phenanthroline-based platinum(II) complexes. Ng NS; Wu MJ; Myers SJ; Aldrich-Wright JR J Inorg Biochem; 2018 Feb; 179():97-106. PubMed ID: 29197671 [TBL] [Abstract][Full Text] [Related]
2. The cytotoxicity of some phenanthroline-based antimicrobial copper(II) and ruthenium(II) complexes. Ng NS; Wu MJ; Aldrich-Wright JR J Inorg Biochem; 2018 Mar; 180():61-68. PubMed ID: 29247868 [TBL] [Abstract][Full Text] [Related]
3. Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes. Matos CP; Addis Y; Nunes P; Barroso S; Alho I; Martins M; Matos APA; Marques F; Cavaco I; Costa Pessoa J; Correia I J Inorg Biochem; 2019 Sep; 198():110727. PubMed ID: 31195153 [TBL] [Abstract][Full Text] [Related]
4. Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand. Parsekar SU; Singh M; Mishra DP; Antharjanam PKS; Koley AP; Kumar M J Biol Inorg Chem; 2019 May; 24(3):343-363. PubMed ID: 30887122 [TBL] [Abstract][Full Text] [Related]
5. Anticancer Effect of Pt Elias MG; Fatima S; Mann TJ; Karan S; Mikhael M; de Souza P; Gordon CP; Scott KF; Aldrich-Wright JR Cancers (Basel); 2024 Jul; 16(14):. PubMed ID: 39061185 [TBL] [Abstract][Full Text] [Related]
6. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV). Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719 [TBL] [Abstract][Full Text] [Related]
7. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents? Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480 [TBL] [Abstract][Full Text] [Related]
8. A hybrid platinum drug dichloroacetate-platinum(II) overcomes cisplatin drug resistance through dual organelle targeting. Zhang Y; Guo G; Ma B; Du R; Xiao H; Yang X; Li W; Gao Y; Li Y; Jing X Anticancer Drugs; 2015 Aug; 26(7):698-705. PubMed ID: 25811961 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, Characterization, and Cytotoxicity Evaluation of Novel Water-Soluble Cationic Platinum(II) Organometallic Complexes with Phenanthroline and Imidazolic Ligands. Ali A; Stefàno E; De Castro F; Ciccarella G; Rovito G; Marsigliante S; Muscella A; Benedetti M; Fanizzi FP Chemistry; 2024 Jul; 30(38):e202401064. PubMed ID: 38703115 [TBL] [Abstract][Full Text] [Related]
10. Molecular, cellular and pharmacological effects of platinum(II) diiodido complexes containing 9-deazahypoxanthine derivatives: A group of broad-spectrum anticancer active agents. Vančo J; Trávníček Z; Křikavová R; Gáliková J; Dvořák Z; Chalupová M J Photochem Photobiol B; 2017 Aug; 173():423-433. PubMed ID: 28662469 [TBL] [Abstract][Full Text] [Related]
11. Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints. Kuang J; He G; Huang Z; Khokhar AR; Siddik ZH Clin Cancer Res; 2001 Nov; 7(11):3629-39. PubMed ID: 11705886 [TBL] [Abstract][Full Text] [Related]
12. The antimicrobial efficacy and DNA binding activity of the copper(II) complexes of 3,4,7,8-tetramethyl-1,10-phenanthroline, 4,7-diphenyl-1,10-phenanthroline and 1,2-diaminocyclohexane. Ng NS; Wu MJ; Jones CE; Aldrich-Wright JR J Inorg Biochem; 2016 Sep; 162():62-72. PubMed ID: 27293146 [TBL] [Abstract][Full Text] [Related]
13. Platinum(II) carboxylato complexes containing 7-azaindoles as N-donor carrier ligands showed cytotoxicity against cancer cell lines. Štarha P; Trávníček Z; Pazderová L; Dvořák Z J Inorg Biochem; 2016 Sep; 162():109-116. PubMed ID: 27350081 [TBL] [Abstract][Full Text] [Related]
14. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin. Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700 [TBL] [Abstract][Full Text] [Related]
15. The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators. Kemp S; Wheate NJ; Buck DP; Nikac M; Collins JG; Aldrich-Wright JR J Inorg Biochem; 2007 Jul; 101(7):1049-58. PubMed ID: 17544512 [TBL] [Abstract][Full Text] [Related]
16. Platinum(II) Complexes with 1,10-Phenanthroline and Hydrophilic Alkoxyacetate Ligands as Potential Antitumor Agents. Sun Y; Wei H; Zhang Q; Zhao X Chem Biodivers; 2019 Jan; 16(1):e1800373. PubMed ID: 30414350 [TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity. Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355 [TBL] [Abstract][Full Text] [Related]
18. Multifaceted Studies of the DNA Interactions and In Vitro Cytotoxicity of Anticancer Polyaromatic Platinum(II) Complexes. Pages BJ; Sakoff J; Gilbert J; Rodger A; Chmel NP; Jones NC; Kelly SM; Ang DL; Aldrich-Wright JR Chemistry; 2016 Jun; 22(26):8943-54. PubMed ID: 27219069 [TBL] [Abstract][Full Text] [Related]
19. Gold(III) compounds-mediated inhibition of lung cancer cell proliferation. Bostancioğlu RB; Kaya M; Koparal AT; Benkli K Anticancer Drugs; 2016 Mar; 27(3):225-34. PubMed ID: 26825752 [TBL] [Abstract][Full Text] [Related]